Search research articles
Contact Us
Filters
Showing results (1461-1470 of 1,873) with videos related to
Page
of 188
Sort By:
European Journal of Heart Failure
|
May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
Carolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
European Journal of Heart Failure
|
March 2, 2026
Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF
Misato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
JACC. Heart Failure
|
October 13, 2023
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial
Maria Pabon, Jon Cunningham, Brian Claggett, et al.
The American Journal of Cardiology
|
February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)
Aliza Hussain, Olive Tang, Caroline Sun, et al.
European Journal of Heart Failure
|
February 17, 2021
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial
Jawad H Butt, Jose C Nicolau, Subodh Verma, et al.
JACC. Heart Failure
|
July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial
Mauro Gori, Michele Senni, Brian Claggett, et al.
European Journal of Heart Failure
|
March 27, 2020
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome
Sung-Hee Shin, Brian Claggett, Marc A Pfeffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Cyclic peptides can engage a single binding pocket through highly divergent modes
Karishma Patel, Louise J Walport, James L Walshe, et al.
JAMA Cardiology
|
November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry
Muthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Nature Communications
|
September 18, 2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T Huang, Bernardo Garcia-Carreras, Matt D T Hitchings, et al.
Page
of 188
Search research articles
Search
Showing results (1461-1470 of 1,873) with videos related to
Sort By:
Page
of 188
European Journal of Heart Failure
|
May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
Carolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
European Journal of Heart Failure
|
March 2, 2026
Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF
Misato Chimura, Kieran F Docherty, Pardeep S Jhund, et al.
JACC. Heart Failure
|
October 13, 2023
Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial
Maria Pabon, Jon Cunningham, Brian Claggett, et al.
The American Journal of Cardiology
|
February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)
Aliza Hussain, Olive Tang, Caroline Sun, et al.
European Journal of Heart Failure
|
February 17, 2021
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial
Jawad H Butt, Jose C Nicolau, Subodh Verma, et al.
JACC. Heart Failure
|
July 11, 2021
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial
Mauro Gori, Michele Senni, Brian Claggett, et al.
European Journal of Heart Failure
|
March 27, 2020
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome
Sung-Hee Shin, Brian Claggett, Marc A Pfeffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 13, 2020
Cyclic peptides can engage a single binding pocket through highly divergent modes
Karishma Patel, Louise J Walport, James L Walshe, et al.
JAMA Cardiology
|
November 13, 2020
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry
Muthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, et al.
Nature Communications
|
September 18, 2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T Huang, Bernardo Garcia-Carreras, Matt D T Hitchings, et al.
Page
of 188